Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

3.390

-0.160 (-4.51%)

At close: Jan 30, 2026, 4:00 PM EST

3.390

0.00 (0.00%)

After-hours: Jan 30, 2026, 7:44 PM EST

Esperion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	798	433	340	459	306	725
Market Cap Growth	83.30%	27.49%	-25.93%	49.97%	-57.77%	-55.52%
Enterprise Value	1,307	848	757	815	726	687
Last Close Price	3.39	2.20	2.99	6.23	5.00	26.00
Forward PE	11.02	16.60	-	-	-	-
PS Ratio	2.20	1.30	2.92	6.08	3.90	3.19
PB Ratio	-	-1.11	-0.75	-1.42	-1.55	-7.54
EV/Sales Ratio	4.30	2.55	6.51	10.79	9.26	3.02
EV/EBITDA Ratio	-	15.58	-	-	-	-
EV/EBIT Ratio	-	15.59	-	-	-	-
Debt / Equity Ratio	-1.33	-1.52	-1.19	-1.56	-2.63	-3.77
Debt / EBITDA Ratio	-	10.29	-	-	-	-
Asset Turnover	0.90	1.21	0.51	0.24	0.21	0.80
Inventory Turnover	1.55	1.43	2.57	4.19	4.76	-
Quick Ratio	0.59	0.91	0.84	2.17	3.85	3.37
Current Ratio	1.00	1.37	1.29	2.67	4.49	3.68
Return on Assets (ROA)	-5.42%	12.37%	-42.86%	-35.64%	-36.31%	-26.73%
Return on Capital Employed (ROCE)	-589.10%	55.70%	-313.80%	-115.30%	-69.30%	-46.80%
Earnings Yield	-13.26%	-11.94%	-61.54%	-50.90%	-87.91%	-19.81%
FCF Yield	-11.69%	-5.53%	-39.85%	-38.09%	-86.18%	-11.87%
Buyback Yield / Dilution	-18.70%	-81.54%	-55.26%	-129.76%	-5.20%	-1.42%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q